Sorry, you need to enable JavaScript to visit this website.

Home

Investors
IR Releases

Investors

Print

Text size: view with small font size; view with medium font size; view with large font size

IR Releases

株主・投資家の皆様

IR Releases

May 01, 2025 Appendix to the Consolidated Financial Summary Fiscal 2025 First Quarter （1,451KB）
May 01, 2025 Consolidated Financial Summary Fiscal 2025 First Quarter （644KB）
March 31, 2025 Matters Concerning Controlling Shareholders （129KB）
March 19, 2025 Corporate Governance Report （933KB）
March 19, 2025 Notice Regarding Disposal of Treasury Shares Used for Restricted Share-Based Remuneration and Performance-Linked Share-Based Remuneration （206KB）
March 08, 2025 AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS （435KB）
February 06, 2025 Appendix to the Consolidated Financial Summary Fiscal 2024 （1,285KB）
February 06, 2025 Consolidated Financial Summary Fiscal 2024 （775KB）
November 21, 2024 Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias （137KB）
October 31, 2024 Notice Regarding Changes of Representative Directors （150KB）
October 31, 2024 Appendix to the Consolidated Financial Summary Fiscal 2024 Third Quarter （1,261KB）
October 31, 2024 Consolidated Financial Summary Fiscal 2024 Third Quarter （687KB）
October 11, 2024 Notice Regarding the Status of Acquisition of Own Shares, Completion of Acquisition and Cancellation of Treasury Shares （101KB）
October 02, 2024 Notice Regarding the Status of Acquisition of Own Shares （97KB）
September 03, 2024 Notice Regarding the Status of Acquisition of Own Shares （96KB）
August 02, 2024 Notice Regarding the Status of Acquisition of Own Shares （101KB）
August 01, 2024 Announcement regarding the restructuring of APAC region business and Change in a Specified Subsidiary （138KB）
August 01, 2024 Consolidated Financial Summary (IFRS) Fiscal 2024 Semi Annual （667KB）
August 01, 2024 Appendix to the Consolidated Financial Summary Fiscal 2024 Semi Annual （996KB）
July 02, 2024 Notice Regarding the Status of Acquisition of Own Shares （96KB）
June 17, 2024 Corporate Governance Report (Partial Correction) （703KB）
June 04, 2024 Notice Regarding the Status of Acquisition of Own Shares （95KB）
May 14, 2024 Corporate Governance Report (Partial Correction) （921KB）
May 07, 2024 Consolidated Financial Summary Fiscal 2024 First Quarter （574KB）
May 07, 2024 Appendix to the Consolidated Financial Summary Fiscal 2024 First Quarter （1,260KB）
May 02, 2024 Notice Regarding the Status of Acquisition of Own Shares （95KB）
April 02, 2024 Notice Regarding the Status of Acquisition of Own Shares （95KB）
March 29, 2024 Matters Concerning Controlling Shareholders （125KB）
March 25, 2024 Corporate Governance Report （992KB）
March 22, 2024 Notice Regarding Disposal of Treasury Shares Used for Restricted Share-Based Remuneration and Performance-Linked Share-Based Remuneration （119KB）
March 04, 2024 Notice Regarding the Status of Acquisition of Own Shares （73KB）
February 07, 2024 Notice regarding Acquisition of Own Shares and Cancellation of Treasury Shares （74KB）
February 07, 2024 Appendix to the Consolidated Financial Summary Fiscal 2023 （1,189KB）
February 07, 2024 Consolidated Financial Summary Fiscal 2023 （846KB）
January 25, 2024 Notice regarding Completion of Share Acquisition of Orchard Therapeutics plc (overview of the acquisition) （80KB）
January 24, 2024 Notice regarding Completion of Share Acquisition of Orchard Therapeutics plc （73KB）
November 14, 2023 (Collection) "Appendix to the Consolidated Financial Summary Fiscal 2023 Third Quarter" （305KB）
November 01, 2023 Consolidated Financial Summary Fiscal 2023 Third Quarter （674KB）
November 01, 2023 Appendix to the Consolidated Financial Summary Fiscal 2023 Third Quarter （845KB）
October 05, 2023 Notice regarding Agreement to acquire Shares of UK biopharmaceutical company Orchard Therapeutics plc （87KB）
August 04, 2023 (Correction) Appendix to the Consolidated Financial Summary Fiscal 2023 Second Quarter （130KB）
August 03, 2023 Appendix to the Consolidated Financial Summary Fiscal 2023 Second Quarter （932KB）
August 03, 2023 Consolidated Financial Summary Fiscal 2023 Second Quarter （703KB）
June 27, 2023 Annual Report 2022 （5,277KB）
May 10, 2023 Appendix to the Consolidated Financial Summary Fiscal 2023 First Quarter （1,730KB）
May 10, 2023 Consolidated Financial Summary Fiscal 2023 First Quarter （655KB）
March 31, 2023 Matters Concerning Controlling Shareholders （55KB）
March 27, 2023 Corporate Governance Report （754KB）
March 24, 2023 Notice Regarding Disposal of Treasury Shares Used for Restricted Share-Based Remuneration （82KB）
March 23, 2023 Annual Securities Report Fiscal 2022 （1,814KB）
February 07, 2023 Appendix to the Consolidated Financial Summary Fiscal 2022 （1,444KB）
February 07, 2023 Consolidated Financial Summary Fiscal 2022 （819KB）
December 06, 2022 Notice Concerning Record of Inpairment Loss and Revisions to Financial Earnings Forecast （207KB）
December 06, 2022 MEI Pharma and Kyowa Kirin Announce Discontinuation of Zandelisib Development Outside of Japan Following Recent FDA Meeting （230KB）
November 04, 2022 Appendix to the Consolidated Financial Summary Fiscal 2022 Third Quarter （1,494KB）
November 04, 2022 Consolidated Financial Summary Fiscal 2022 Third Quarter （780KB）
August 04, 2022 Consolidated Financial Summary Fiscal 2022 Second Quarter （770KB）
August 04, 2022 Appendix to the Consolidated Financial Summary Fiscal 2022 Second Quarter （1,446KB）
May 21, 2022 Annual Report 2021 （4,535KB）
May 10, 2022 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2022 First Quarter （833KB）
May 10, 2022 Consolidated Financial Summary (IFRS) Fiscal 2022 First Quarter （735KB）
March 31, 2022 Matters Concerning Controlling Shareholders （106KB）
March 26, 2022 Corporate Governance Report March 25, 2022 （877KB）
March 25, 2022 Notice Regarding Disposal of Treasury Shares Used for Restricted Share-Based Remuneration （200KB）
February 22, 2022 Notice Regarding Partial Amendments to the Articles of Incorporation （196KB）
February 07, 2022 Notice Regarding Recording of Extraordinary Income in Non-consolidated Finacial Statements （110KB）
February 07, 2022 Appendix to the Consolidated Financial Summary Fiscal 2021 （857KB）
February 07, 2022 Consolidated Financial Summary Fiscal 2021 （842KB）
December 24, 2021 Corporate Governance Report （823KB）
November 01, 2021 Appendix to the Consolidated Financial Summary Fiscal 2021 Third Quarter （868KB）
November 01, 2021 Consolidated Financial Summary Fiscal 2021 Third Quarter （741KB）
August 03, 2021 Appendix to the Consolidated Financial Summary Fiscal 2021 Interim （890KB）
August 03, 2021 Consolidated Financial Summary Fiscal 2021 Second Quarter （720KB）
May 29, 2021 Annual Report 2020 （8,734KB）
May 06, 2021 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2021 First Quarter （810KB）
May 06, 2021 Consolidated Financial Summary (IFRS) Fiscal 2021 First Quarter （592KB）
March 31, 2021 Matters Concerning Controlling Shareholders （119KB）
March 24, 2021 Corporate Governance Report （672KB）
March 24, 2021 Notice Regarding Disposal of Treasury Shares Used for Restricted Share-Based Remuneration （196KB）
March 22, 2021 (Updated) Matters Concerning Controlling Shareholders （107KB）
February 18, 2021 Notice Regarding Introduction of Performance-linked Share-based Remuneration Plan （108KB）
February 04, 2021 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2020 （346KB）
February 04, 2021 Consolidated Financial Summary (IFRS) Fiscal 2020 （601KB）
October 30, 2020 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2020 Third Quarter （605KB）
October 30, 2020 Consolidated Financial Summary (IFRS) Fiscal 2020 Third Quarter （2,152KB）
July 30, 2020 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2020 Interim （573KB）
July 30, 2020 Consolidated Financial Summary (IFRS) Fiscal 2020 Interim （2,122KB）
May 01, 2020 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2020 First Quarter （580KB）
May 01, 2020 Consolidated Financial Summary (IFRS) Fiscal 2020 First Quarter （834KB）
April 14, 2020 Annual Report 2019
March 31, 2020 Matters Concerning Controlling Shareholders （100KB）
March 19, 2020 Notice Regarding Disposal of Treasury Shares Used for Restricted Share-Based Remuneration （129KB）
February 20, 2020 Notice Regarding Introduction of Restricted Share-Based Remuneration Plan （87KB）
February 05, 2020 Notice Regarding Partial Amendments to the Articles of Incorporation （116KB）
February 05, 2020 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2019 （765KB）
February 05, 2020 Consolidated Financial Summary (IFRS) Fiscal 2019 （453KB）
October 29, 2019 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2019 Third Quarter （777KB）
October 29, 2019 Consolidated Financial Summary (IFRS) Fiscal 2019 Third Quarter （536KB）
August 01, 2019 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2019 Interim （490KB）
August 01, 2019 Consolidated Financial Summary (IFRS) Fiscal 2019 Interim （252KB）
May 13, 2019 Transcript of Results Presentation Fiscal 2019 First Quarter (including Q&A)
May 08, 2019 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2019 First Quarter （420KB）
May 08, 2019 Consolidated Financial Summary (IFRS) Fiscal 2019 First Quarter （204KB）
April 24, 2019 Notice Concerning Completion of Consolidated Subsidiary Share Transfer （223KB）
April 19, 2019 Annual Report 2018
April 19, 2019 Coprporate Governance Report （1,100KB）
April 10, 2019 Result of Voluntary Early Retirement Offer （222KB）
March 29, 2019 Matters concerning controlling shareholders （122KB）
March 22, 2019 Notice of Resolutions of the 96th Ordinary General Meeting of Shareholders
March 20, 2019 Notice Regarding Allotment of Share Acquisition Rights (Share Remuneration-type Stock Options) （104KB）
February 19, 2019 Notice Regarding Change in Exercise Condition of Share Remuneration-type Stock Options （313KB）
February 19, 2019 Notice Regarding Share Acquisition Rights for Share Remuneration-type Stock Options （237KB）
February 19, 2019 Notice Regarding Partial Amendments to the Articles of Incorporation （237KB）
February 06, 2019 Notice regarding the Result and Completion of Repurchase of Own Shares through Off-Auction Own Share Repurchase Trading (ToSTNet-3) （113KB）
February 05, 2019 Kyowa Hakko Kirin Announces Changes in the Executive Directors （105KB）
February 05, 2019 Notice regarding Repurchase of Own Shares, Purchase of Own Shares through Off-Auction Own Share Repurchase Trading (ToSTNeT-3), and Cancellation of Tr （124KB）
February 05, 2019 Offer of Voluntary Early Retirement （96KB）
February 05, 2019 Consolidated Financial Summary (IFRS) Fiscal 2018 （173KB）
February 05, 2019 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2018 （1,990KB）
February 05, 2019 Notice Concerning Share Transfer Associated with Change in a Consolidated Company and (Expected) Gain on Transfer （310KB）
October 30, 2018 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2018 Third Quarter （396KB）
October 30, 2018 Consolidated Financial Summary (IFRS) Fiscal 2018 Third Quarter （106KB）
July 31, 2018 Notice Regarding Change of Trade Name, Partial Amendments to the Articles of Incorporation, and Change of Location of Head Office （57KB）
July 31, 2018 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2018 Interim （375KB）
July 31, 2018 Consolidated Financial Summary (IFRS) Fiscal 2018 Second Quarter （104KB）
May 08, 2018 Consolidated Financial Summary (IFRS) Fiscal 2018 First Quarter （104KB）
May 08, 2018 Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2018 First Quarter （373KB）
March 30, 2018 Matters concerning controlling shareholders （63KB）

Integrated Report

ESG Data

CSV Materiality and SDGs

GRI Standard Index

Directors & Officers

This website is intended for the use of shareholders and investors.
The "Investors" contents are created and published to provide information on the Company's activities to shareholders and investors and not offer information to the general public.

Are you a shareholder or an investor?

Yes